JP2022553934A5 - - Google Patents
Info
- Publication number
- JP2022553934A5 JP2022553934A5 JP2022522825A JP2022522825A JP2022553934A5 JP 2022553934 A5 JP2022553934 A5 JP 2022553934A5 JP 2022522825 A JP2022522825 A JP 2022522825A JP 2022522825 A JP2022522825 A JP 2022522825A JP 2022553934 A5 JP2022553934 A5 JP 2022553934A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- particle size
- compound
- size distribution
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962923290P | 2019-10-18 | 2019-10-18 | |
| US62/923,290 | 2019-10-18 | ||
| PCT/US2020/056027 WO2021076922A1 (en) | 2019-10-18 | 2020-10-16 | Pharmaceutical formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553934A JP2022553934A (ja) | 2022-12-27 |
| JP2022553934A5 true JP2022553934A5 (https=) | 2023-10-24 |
Family
ID=75492817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522825A Pending JP2022553934A (ja) | 2019-10-18 | 2020-10-16 | 薬学的製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210114973A1 (https=) |
| EP (1) | EP4045480A4 (https=) |
| JP (1) | JP2022553934A (https=) |
| KR (1) | KR20240039083A (https=) |
| CN (1) | CN117597327A (https=) |
| AR (1) | AR122323A1 (https=) |
| CA (1) | CA3157861A1 (https=) |
| TW (1) | TW202128610A (https=) |
| WO (1) | WO2021076922A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3338783B1 (en) | 2014-09-12 | 2024-01-24 | UNION therapeutics A/S | Antibacterial use of halogenated salicylanilides |
| GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
| PE20181295A1 (es) | 2015-09-01 | 2018-08-07 | First Wave Bio Inc | Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala |
| GB201604484D0 (en) | 2016-03-16 | 2016-04-27 | Antibiotx Aps And Københavns Uni University Of Copenhagen | Topical antibacterial compositions |
| US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
| WO2021174024A1 (en) * | 2020-02-28 | 2021-09-02 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| US10980756B1 (en) | 2020-03-16 | 2021-04-20 | First Wave Bio, Inc. | Methods of treatment |
| US11045434B1 (en) | 2020-04-01 | 2021-06-29 | UNION therapeutics A/S | Niclosamide formulations for treating disease |
| US12240813B2 (en) | 2020-05-19 | 2025-03-04 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
| CN113768937B (zh) * | 2021-11-15 | 2022-04-08 | 恒翼生物医药科技(上海)有限公司 | 用于降低尿酸水平的化合物 |
| GB202301306D0 (en) * | 2023-01-30 | 2023-03-15 | Ucl Business Ltd | Treatment of granulomatous disease |
| CN117357523A (zh) * | 2023-10-25 | 2024-01-09 | 澳门大学 | 利拉萘酯在制备预防和治疗肺纤维化药物中的用途 |
| CN117466786A (zh) * | 2023-12-25 | 2024-01-30 | 湖南一格制药有限公司 | 盐酸戊乙奎醚杂质及其制备方法 |
| WO2025207484A1 (en) * | 2024-03-25 | 2025-10-02 | Merveille.Ai | Use of aprepitant and cyclic dipeptide for weight control |
| CN118649135B (zh) * | 2024-07-18 | 2024-12-10 | 广东药科大学 | 一种缓解高尿酸血症肾病进程的药物制剂及其制备方法 |
| CN119525016B (zh) * | 2024-12-24 | 2026-04-07 | 中国矿业大学 | 一种组合捕收剂及其在钾长石反浮选脱硅中的应用 |
| CN119431243B (zh) * | 2025-01-09 | 2025-06-10 | 万邦德制药集团有限公司 | 一种氘代石杉碱甲化合物或其药学上可接受的盐及其制备方法和应用 |
| CN119841970B (zh) * | 2025-01-23 | 2026-02-27 | 集美大学 | 一种具有抗炎活性的乙酰化卡拉胶及其制备方法和应用 |
| CN121406752A (zh) * | 2025-12-26 | 2026-01-27 | 圣湘生物科技股份有限公司 | 粘性生物样本的液化组合产品、核酸检测试剂盒及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2557615C2 (de) * | 1975-12-20 | 1985-08-14 | Bayer Ag, 5090 Leverkusen | Neue Niclosamid-Suspensionsformulierungen |
| NZ223200A (en) * | 1988-01-15 | 1989-01-06 | Ancare Distributors | Anthelmintic compositions containing 2',5-dicloro-4'-nitrosalicylanilide and non aqueous carrier |
| AU2003249244A1 (en) * | 2002-07-15 | 2004-02-02 | Combinatorx, Incorporated | Methods for the treatment of neoplasms |
| CN1546919A (zh) * | 2003-07-13 | 2004-11-17 | 叶声羽 | 桑拿浴房 |
| CN1626506A (zh) * | 2004-08-10 | 2005-06-15 | 李志良 | 高纯度、高收率氯硝柳胺的制备 |
| EP2123626A1 (en) * | 2008-05-21 | 2009-11-25 | Laboratorios del Dr. Esteve S.A. | Co-crystals of duloxetine and co-crystal formers for the treatment of pain |
| CN103751854B (zh) * | 2014-01-20 | 2015-08-26 | 瞿介明 | 抗菌医用导管 |
| PE20181295A1 (es) * | 2015-09-01 | 2018-08-07 | First Wave Bio Inc | Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala |
| EP3168211A1 (en) * | 2015-11-10 | 2017-05-17 | Westfälische Wilhelms-Universität Münster | Pharmaceutical co-crystals of niclosamide |
-
2020
- 2020-04-07 US US16/842,695 patent/US20210114973A1/en not_active Abandoned
- 2020-10-16 KR KR1020227016634A patent/KR20240039083A/ko not_active Ceased
- 2020-10-16 TW TW109136022A patent/TW202128610A/zh unknown
- 2020-10-16 JP JP2022522825A patent/JP2022553934A/ja active Pending
- 2020-10-16 EP EP20877454.7A patent/EP4045480A4/en not_active Withdrawn
- 2020-10-16 CA CA3157861A patent/CA3157861A1/en active Pending
- 2020-10-16 CN CN202080088987.0A patent/CN117597327A/zh active Pending
- 2020-10-16 WO PCT/US2020/056027 patent/WO2021076922A1/en not_active Ceased
- 2020-10-19 AR ARP200102884A patent/AR122323A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022553934A5 (https=) | ||
| US20230310595A1 (en) | Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancers | |
| US12235270B2 (en) | Depleting tumor-specific tregs | |
| ES2729961T3 (es) | Uso de antagonistas del receptor EP4 para su uso en el tratamiento de cáncer de hígado asociado a NASH | |
| Bellan et al. | Role of vitamin D in rheumatoid arthritis | |
| JP2018529762A5 (https=) | ||
| KR20190067235A (ko) | Vista 및 pd-1 경로의 이중 억제제 | |
| JP2018111700A (ja) | 急性骨髄性白血病（ａｍｌ）のための新規併用治療 | |
| HK1251162A1 (en) | Use of ep4 receptor antagonists for the treatment of nash-associated liver cancer | |
| CN115942977A (zh) | Cd73抑制剂的结晶形式及其用途 | |
| CN113301896A (zh) | Ep4抑制剂和其合成 | |
| AU2014225373A1 (en) | Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis | |
| TW202515549A (zh) | 橋聯三環胺甲醯基吡啶酮化合物及其用途 | |
| CN115697317A (zh) | Ep4受体拮抗剂用于治疗肝癌、黑色素瘤、淋巴瘤和白血病的应用 | |
| JP2022513072A5 (https=) | ||
| Naor et al. | 18 a human-derived 5-MER peptide (MTADV), WHICH restrictively alleviates the pro-inflammatory activity OF serum amyloid a (SAA), substantially ameliorates IBD pathology: new potential drug (MTADV) and therapeutic target candidate (SAA) for IBD | |
| Campbell et al. | P101 sarcopenia is associated with increased risk of infection in IBD patients older than 50 years starting biologic medications | |
| US20250177352A1 (en) | Combination treatment for cancer | |
| TW202530227A (zh) | 橋聯三環胺甲醯基吡啶酮化合物及其用途 | |
| AU2020248422A1 (en) | Method of treating malignant rhabdoid tumor of the ovary and small cell cancer of the ovary of the hypercalcemic type | |
| HK1253277B (zh) | Ep4受体拮抗剂用於治疗nash相关肝癌的用途 | |
| EA048934B1 (ru) | Способы лечения рака | |
| EA042615B1 (ru) | Способы лечения синдрома альпорта и улучшения функции почек с использованием бардоксолон-метила |